Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.
Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso. Fougerousse AC, et al. Among authors: becherel pa. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9. J Eur Acad Dermatol Venereol. 2020. PMID: 32564417 Free PMC article. No abstract available.
[Misdiagnosis of hidradenitis suppurativa continues to be a major issue. The R-ENS Verneuil study].
Loget J, Saint-Martin C, Guillem P, Kanagaratnam L, Becherel PA, Nassif A, Fougerousse AC, Siham M, Girard C, Barthelemy H, Chaby G, Gabison G, Perrot JL, Pallure V, Beneton N, Boye T, Jacobzone C, Begon E, Bernard P, Reguiai Z; sous l’égide de « ResoVerneil ». Loget J, et al. Among authors: becherel pa. Ann Dermatol Venereol. 2018 May;145(5):331-338. doi: 10.1016/j.annder.2018.01.043. Epub 2018 Apr 26. Ann Dermatol Venereol. 2018. PMID: 29704958 French.
Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting.
Fougerousse AC, Maccari F, Beauchet A, Parier J, Boulard C, Becherel PA, Quiles-Tsimaratos N, Le Guyadec T, Thomas-Beaulieu D, Halioua B, Begon E, Bastien M, Perrot JL, Pallure V, Bilan P, Steff M, Pfister P, Vermersch-Langlin A, Boyé T, Mery-Bossard L, Maillard H, Kemula M, Girard C, Poiraud C, Monfort JB, Kupfer-Bessaguet I, Perrussel M, Lons-Danic D, Sultan N, Lorier E, Zeitoun M, Wagner L, Gabison G, Mahé E; GEM Resopso. Fougerousse AC, et al. Among authors: becherel pa. J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e476-e478. doi: 10.1111/jdv.15804. Epub 2019 Jul 30. J Eur Acad Dermatol Venereol. 2019. PMID: 31310364 No abstract available.
Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures.
Reguiai Z, Becherel PA, Fougerousse AC, Chaby G, Perrot JL, Begon E, Jacobzone-Lévêque C, Boulard C, Badaoui A, Poreaux C, David L, Quiles-Tsimaratos N, Lons-Danic D, Fite C, Liegeon AL, Patchinsky A, Parier J, Garcia C, Estève E, Mohty R, Mery-Bossard L, Maccari F. Reguiai Z, et al. Among authors: becherel pa. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1307-e1309. doi: 10.1111/jdv.19302. Epub 2023 Jul 14. J Eur Acad Dermatol Venereol. 2023. PMID: 37415328 No abstract available.
Protease-modulating polyacrylate-based hydrogel stimulates wound bed preparation in venous leg ulcers--a randomized controlled trial.
Humbert P, Faivre B, Véran Y, Debure C, Truchetet F, Bécherel PA, Plantin P, Kerihuel JC, Eming SA, Dissemond J, Weyandt G, Kaspar D, Smola H, Zöllner P; CLEANSITE study group. Humbert P, et al. Among authors: becherel pa. J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1742-50. doi: 10.1111/jdv.12400. Epub 2014 Feb 26. J Eur Acad Dermatol Venereol. 2014. PMID: 24612304 Free PMC article. Clinical Trial.
[Facial edema].
Pernès JM, Carcone B, Becherel PA, Hamrouni A. Pernès JM, et al. Among authors: becherel pa. Rev Med Interne. 2014 May;35(5):341-3. doi: 10.1016/j.revmed.2013.07.003. Epub 2013 Aug 16. Rev Med Interne. 2014. PMID: 23958231 French. No abstract available.
Clinical Characteristics and Therapeutic Management of Atopic Dermatitis in Elderly Patients Compared with Young Adult Patients: A Prospective Multicentre Study.
Pollyn-Millot C, Maccari F, Perrot JL, Reguiai Z, Boulard C, Becherel PA, Poreaux C, Mery-Bossard L, Beaulieu D, Pourchot D, Fougerousse AC, Begon E, Liegeon AL, Fite C, Zaraa I, Lons-Danic D, Walls B, Jacobzone C, Lepelley C, Denis D, Chaby G; OMCCI Group. Pollyn-Millot C, et al. Among authors: becherel pa. Acta Derm Venereol. 2024 Sep 9;104:adv40420. doi: 10.2340/actadv.v104.40420. Acta Derm Venereol. 2024. PMID: 39248293 Free PMC article.
Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort - A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses.
Becherel PA, Reguiai Z, Fougerousse AC, Perrot JL, Begon E, Thomas-Beaulieu D, Mery-Bossard L, Pourchot D, Boulard C, Fite C, Beaziz J, Zaraa I, Lons-Danic D, Badaoui A, Parier J, Chaby G, Estève E, Liegeon AL, Patchinsky A, Muller P, Lepelley-Dupont C, Poreaux C, Jacobzone-Lévêque C, Chassain K, Mohty R, Perrussel M, Garcia C, Girard C, Dillies AS, Amy de la Breteque M, Quiles-Tsimaratos N, Denis D, Maccari F. Becherel PA, et al. Dermatology. 2024 Jul 17:1-11. doi: 10.1159/000540250. Online ahead of print. Dermatology. 2024. PMID: 39019015
Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study).
Reguiai Z, Becherel PA, Perrot JL, Boulard C, Fougerousse AC, Begon E, Badaoui A, Poreaux C, Parier J, Liegeon AL, Levavasseur M, Bing AC, Estève E, Maccari F; GEM reso‐Dermatologie and OMCCI Group. Reguiai Z, et al. Among authors: becherel pa. J Eur Acad Dermatol Venereol. 2024 Nov;38(11):2149-2155. doi: 10.1111/jdv.20233. Epub 2024 Jul 17. J Eur Acad Dermatol Venereol. 2024. PMID: 39015045
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
Reguiai Z, Becherel PA, Perrot JL, Fougerousse AC, Begon E, Poreaux C, Boulard C, Chaby G, Fite C, Zaraa I, Lons-Danic D, Liegeon AL, Parier J, Quiles-Tsimaratos N, David L, Maccari F. Reguiai Z, et al. Among authors: becherel pa. Acta Derm Venereol. 2023 Oct 6;103:adv14153. doi: 10.2340/actadv.v103.14153. Acta Derm Venereol. 2023. PMID: 37800349 Free PMC article.
49 results